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Abstract
Degradation of extracellular matrix, particularly interstitial collagen, promotes plaque instability and contributes to restenosis
after vascular injury. We have explored the effects of vitamins C and E on the collagen content and metalloproteinase-1 (MMP-1)
expression after angioplasty in hypercholesterolemic pigs. Iliac angioplasty was performed on 18 minipigs divided into three diet
groups: a normal-cholesterol (NC), a high-cholesterol (HC) and a high-cholesterol plus vitamins C/E (HCV). Four weeks later,
after sacrifice, the vascular collagen content and MMP-1 protein expression, along with the plasma caseinolytic activity and lipid
peroxidation, were measured. MMP-1 was also determined in arterial rings stimulated with native low-density lipoproteins (LDL)
isolated from experimental groups. Cholesterol-rich diet augmented plasma lipid peroxidation (PB/0.05), reduced the collagen
content and increased vascular MMP-1 expression after injury (PB/0.05). Enhanced caseinolytic activity (identified as MMP-1) was
also observed in HC plasma samples and in supernatants from arterial rings incubated with HC-LDL. Vitamins C and E markedly
increased neointimal collagen content (PB/0.01), reduced the hypercholesterolemia-induced changes in vascular MMP-1 (PB/0.05)
and diminished plasma and ex vivo caseinolytic activity. Vitamins C and E may help stabilize atherosclerotic plaque after
angioplasty and favor vascular remodeling by increasing collagen content and reducing vascular MMP-1 expression in porcine
hypercholesterolemia.
# 2002 Elsevier Science Ireland Ltd. All rights reserved.
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1. Introduction
Degradation of extracellular matrix (ECM) contri-
butes crucially to a variety of processes, including
atherosclerosis and restenosis after vascular injury and
is a critical event leading to the weakening of the vessel
wall [1,2]. ECM degradation by metalloproteinases
(MMPs) is known to be involved in the pathogenesis
of cardiovascular diseases, including atherosclerosis,
restenosis and myocardial infarction [3]. MMPs are a
family of zinc-dependent enzymes that can be divided
into two structurally distinct groups, such as secreted
MMPs and membrane-type MMPs. Secreted MMPs
include collagenases (MMP-1, MMP-8), gelatinases
(MMP-2, MMP-9) stromelysins (MMP-3, MMP-10)
and other MMPs. MMP-1 secreted from cells present
in atheroma could be involved in the subendothelial
destruction of ECM and remodeling of plaques [3,4].
Previous studies have demonstrated that hypercho-
lesterolemia induces local collagen loss, contributing to
plaque destabilization [5]. Although the mechanisms
involved in these processes are still unclear, it has been
suggested that the activation of cells in atheroma could
be a principle source of MMPs. oxLDL stimulate
macrophage activation and induce the expression of
MMP-1 by vascular cells [6]; this proteinase is known to
play a prominent role in plaque stability [7] and, in
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addition, lipid lowering has been shown to reduce
MMP-1 activity and increase collagen content of
atheroma [8].
Antioxidant vitamins have been evaluated through
clinical studies for their association with atherosclerotic
disease, but their results are not conclusive. Recent
clinical trials enrolling patients with established athero-
sclerosis or at high vascular risk, have failed to
demonstrate that vitamin E reduces the progression of
the disease [9]. In contrast, other studies have demon-
strated that antioxidant vitamins retard the development
of coronary arteriosclerosis [10]. In experimental mod-
els, we and others have previously shown that antiox-
idants are able to reduce intimal lesions, decrease type-1
plasminogen activator inhibitor (PAI-1) after injury and
restore endothelial function [11/13], but their possible
effect on the regulation of MMPs and/or neointimal
collagen content has not been properly assessed.
The pig model appears to be the most relevant to
human restenosis because of its similarities with human
coronary circulation, spontaneous development of
atherosclerosis and histological response to vascular
injury [14]. We hypothesized that antioxidant vitamins
C and E would preserve the collagen content in a
hypercholesterolemic porcine model of angioplasty,
possibly by reducing the MMP-1 expression. Treatment
with vitamins was initiated 3 weeks after the induction
of hypercholesterolemia in order to more closely mimic
a potential clinical situation.
2. Material and methods
2.1. Animals
Eighteen Yucatan miniature pigs (4 months old, mean
weight 33.299/1.69 kg) were obtained from our breeding
center and maintained in the animal facilities at CIFA
(Centro de Investigacio´n en Fa´rmaco-Biologı´a Apli-
cada), a GLP-accredited center within the University of
Navarra (Pamplona, Spain). Housing conditions fol-
lowed the European regulations (86/609/CEE).
2.2. Biochemical measurements
Concentrations of total serum cholesterol and its
fractions were determined by standard enzymatic assays.
Plasma lipid peroxidation was measured as thiobar-
bituric acid reactive substances (TBARS) [15]. Vitamin
E was measured in plasma using a reverse-phase high-
performance liquid chromatography (HPLC) [13].
2.3. Vascular injury and tissue processing
Our model of vascular lesion after iliac angioplasty in
hypercholesterolemic pigs has recently been described
[11]. Briefly, animals were divided into three groups
(n/6) and fed different dietary formulations for 4
weeks: a normal-cholesterol (NC) control group, given
standard porcine chow (Porcisanders, Sanders); a high-
cholesterol (HC) group fed with a diet containing 24.5%
animal lard, 4% cholesterol (Roig Farma) and 1.5%
biliar extract (Roig Farma); and a high-cholesterol plus
vitamins C and E (HCV) group fed similar to the HC
group, but supplemented during the last week with 1 g
vitamin C and 1000 IU vitamin E (Roig Farma) per
animal per day. The dosage of antioxidants was chosen
from a similar model demonstrating that animals treated
with vitamins C and E have a smaller degree of LDL
oxidation and the best response to vascular injury [12].
At this time, the animals were subjected to catheteriza-
tion in the right internal iliac artery, the left internal iliac
artery was used as control. The animals from each group
were allowed to recover and maintained their designated
diets until they were sacrificed, 28 days after interven-
tion.
Vascular tissues were fixed with paraformaldehyde
4%, dehydrated and paraffin-embedded for histological
purposes. Arterial blood samples were drawn before and
after arterial injury for analytical measurements.
2.4. Immunohistological analysis
Sirius red staining was used to identify interstitial
collagen on serial 3 mm sections as previously described
[16].
Tissue sections for MMP-1 immunohistochemistry
were heated in sodium citrate buffer (0.01 M, pH/6)
for antigen retrieval before their incubation with 2 mg/ml
murine anti-MMP-1, which recognizes both active and
latent forms (IM35L Oncogen, USA), 0.5 mg/ml murine
anti-a-smooth muscle actin (M850, Dako, Denmark)
and murine anti-swine leukocyte Ag monoclonal anti-
body 4E9 [17] (kindly provided by Dr J. Dominguez,
INIA, Spain). All sections were incubated with second-
ary biotinylated rabbit anti-mouse Fc (Dako), devel-
oped with avidin-biotin-peroxidase complex (ABC,
Dako, Denmark) and 3-3?-diaminobenzidine hydrochlo-
ride (Sigma, USA) and counterstained with Harris’
hematoxylin [11].
A visual grading scale was used for assessing the
intensity of MMP-1 immunostaining. Three observers,
independently and in a blinded fashion, characterized
sections by comparing them against a control section
using the grading scale. Each observer evaluated and
scored each field on a 0 to 3/ scale for the extent
distribution of positive staining [11].
2.5. Effect of porcine LDL on MMP-1 ex vivo expression
Coronary artery rings (n/9) were incubated for 48 h
with native LDL (100 mg protein/ml) isolated from
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porcine plasma from experimental groups (NC, HC and
HCV) by density gradient ultracentrifugation [18].
Supernatants of cultured rings were separated by SDS-
PAGE under reducing conditions in Tris/glycine/SDS
buffer (pH 8.3), electroblotted onto nitrocellulose mem-
brane and probed with murine anti-MMP-1 (1 mg/ml),
followed by a peroxidase-linked rabbit anti-mouse IgG
(1:2000, Zymed, USA). Blots were developed using a
chemiluminescence system (ECL, Amersham-
Bioscience), on X-ray film. Human recombinant
MMP-1 (Amersham Bioscience) was used as the positive
control.
2.6. Zymographic analysis
Some 10 ml of coronary supernatants or a 1:20
dilution of plasma samples in saline were loaded on a
standard 8% SDS-PAGE gel containing 0.5% casein and
electrophoresed under non-reducing conditions. Sub-
strate gels were soaked with Triton X-100 solution
(2.5%) for 15 min at room temperature and then
incubated overnight at 37 8C with a 50 mM Tris/HCl
buffer (pH 7.4, 0.05% NaCl, 0.1% NaN3 and 10 mM
CaCl2). The lysis of the casein in the gel was visualized
by staining with Coomassie brilliant blue (Sigma),
densitometrically quantified on a GS690 system (Bio-
Rad) and identified on the basis of protein electro-
phoretic mobility [19]. Quenching analysis were per-
formed by simultaneous incubation of plasma samples
with 5/50 ng of a monoclonal antibody anti-MMP-1
(Oncogene).
2.7. Statistical analysis
All data was expressed as mean9/S.E.M. Statistically
significant differences between groups were calculated
by analysis of variance (ANOVA) followed by Tukey
posthoc test or Kruskal/Wallis and Mann/Whitney
test, for parametric and non-parametric conditions,
respectively. Statistical significance was accepted at the
95% confidence level (PB/0.05). Association between
variables was assessed by using the Spearman’s correla-
tion test. Analysis was performed by using the computer
program SPSS for Windows (SPSS Inc).
3. Results
3.1. Plasma cholesterol, lipid peroxidation and lesion
formation
As shown in Table 1, pigs receiving hypercholester-
olemic diet showed higher cholesterol concentration
(PB/0.01) and plasma lipid peroxidation (PB/0.01)
than the controls. The angioplasty induced severe
structural changes in the vascular wall in comparisonT
a
b
le
1
B
io
ch
em
ic
a
l
m
ea
su
re
m
en
ts
a
n
d
m
o
rp
h
o
m
et
ri
c
a
n
a
ly
si
s
o
f
il
ia
c
a
rt
er
ie
s
in
th
e
p
o
rc
in
e
m
o
d
el
o
f
a
n
g
io
p
la
st
y
2
8
d
a
y
s
a
ft
er
in
ju
ry
G
ro
u
p
T
o
ta
l-
ch
o
le
st
er
o
l
(m
M
)
V
it
a
m
in
E
(m
M
)
V
it
a
m
in
E
/t
o
ta
l-
ch
o
le
st
er
o
l
T
B
A
R
S
(n
M
)
In
ti
m
a
l
a
re
a
(m
m
2
)
S
te
n
o
si
s
(%
)
M
ed
ia
ce
ll
d
en
si
ty
(1
0
2
ce
ll
s/
m
m
2
)
N
C
1
.6
9
/0
.1
1
.9
9
/0
.9
1
.1
1
9
/0
.4
1
3
5
7
.9
9
/4
9
.4
1
.2
9
/0
.5
4
2
.2
9
/1
2
.9
3
8
.6
9
/1
.5
H
C
5
.9
9
/1
.5
*
*
1
.8
9
/0
.5
0
.3
0
9
/0
.0
3
5
5
3
.4
9
/6
6
.9
*
*
1
.7
9
/0
.6
2
6
.6
9
/4
.6
4
9
.6
9
/2
.3
H
C
V
5
.4
9
/5
.4
*
*
1
5
.9
9
/1
.9
*
*
,$
$
3
.0
3
9
/0
.3
2
*
,$
$
2
1
2
.5
9
/4
3
.7
*
0
.8
9
/0
.1
$
2
8
.6
9
/2
.7
3
5
.4
9
/2
.7
*
D
if
fe
re
n
ce
s
fr
o
m
N
C
a
s
P
B
/0
.0
5
.
*
*
D
if
fe
re
n
ce
s
fr
o
m
N
C
a
s
P
B
/0
.0
1
.
$
D
if
fe
re
n
ce
s
fr
o
m
H
C
a
s
P
B
/0
.0
5
.
$$
D
if
fe
re
n
ce
s
fr
o
m
H
C
a
s
P
B
/0
.0
1
.
J. Orbe et al. / Atherosclerosis 167 (2003) 45/53 47
with uninjured arteries, resulting in an increased intimal
area and media cell density in HC group compared to
the NC group (data not shown).
Treatment with vitamins C and E had no effect on
total cholesterol or LDL concentration, but, as ex-
pected, it increased plasma vitamin E levels and,
particularly, the vitamin E content in the LDL fraction
compared with HC (14.59/3.6 vs. 4.299/2.1 nM/mg
protein, PB/0.05). As shown in Table 1, antioxidant
treatment significantly reduced the hypercholesterole-
mia-induced plasma lipid peroxidation at the time of
sacrifice (PB/0.01), without significant improvement in
morphologic parameters, except a slight, but significant,
reduction in the intimal area (PB/0.05).
3.2. Atherosclerotic lesion collagen content
Vascular sections stained for collagen with Sirius red
were analyzed under polarized light. As shown in Fig. 1,
the lesions in the NC group were intensely stained for
collagen fibers forming intricate networks throughout
the plaque (Fig. 1A). However, the collagen content was
practically absent throughout the vascular wall in the
HC group (Fig. 1B), whereas a significant recovery was
observed in the HCV group (Fig. 1C). The collagen
stained area in plaques was 2.4-fold higher in the NC
group than in HC group (70.89/8.1% vs. 29.39/8.9%,
PB/0.01). Antioxidant vitamins C and E significantly
restored the collagen content with respect to HC (65.59/
7.4% vs. 29.39/8.9%, PB/0.01) without differences
regarding the NC group.
3.3. MMP activity
Since no vascular samples were available for zymo-
graphy, we performed caseinolytic analysis of plasma
samples in order to determine whether hypercholester-
olemia induces increased systemic proteolytic activity. A
similar proteolytic profile activity was observed in all of
the experimental groups, but a more intense 52 kDa
proteolytic band was found in the samples obtained
after injury in the HC group than in the NC group (PB/
0.05, Fig. 2A). However, as shown in Fig. 2(A), the 52
kDa caseinolytic activity was reduced in the group
treated with antioxidants in comparison to the HC
group, indicating that in addition to local effects on
collagen content, vitamins C and E also reduced the
systemic proteolytic activity. In order to identify the
caseinolytic band, additional experiments were per-
formed by preincubating plasma samples with different
concentrations of specific MMP-1 antibody. As shown
in Fig. 2(B), a dose-dependent reduction in the proteo-
lytic activity was found, indicating that it corresponds to
MMP-1.
Taking a further step, we performed immunohisto-
chemical analysis for MMP-1 in vascular sections in
Fig. 1. Sirius red staining of vascular tissue sections from the three experimental groups, photographed with a polarizing filter. Intense collagen loss
was observed in the injured HC arteries (panel B) in comparison with the NC group (panel A). Treatment with vitamins C and E induced a significant
increase in the collagen content of vascular sections (panel C).
J. Orbe et al. / Atherosclerosis 167 (2003) 45/5348
order to assess whether MMP-1 expression could be
associated with observed modifications in collagen
content within vascular vessels in the experimental
groups. As shown in Fig. 3, MMP-1 protein was
significantly increased in the neointima and media layers
of HC group compared to NC (PB/0.05, Fig. 3A, B).
Median quantitative score for MMP-1 immunostaining
was also found to be significantly higher (PB/0.05) in
the HC group (Table 2). The most intense signal was
observed within the vascular lesion, near the media and
in the thickened intima (Fig. 3D). Areas with the most
intense signal were also positive for a-actin smooth
muscle cells (SMC) and macrophages, suggesting that
these cellular types are involved in MMP-1 vascular
expression (Fig. 3E, F).
Interestingly, the antioxidant treatment was able to
significantly reduce the observed vascular MMP-1
expression in response to injury in the HCV group.
Immunohistochemical analysis showed weaker MMP-1
reactivity in the media and in the thickened intima in the
group of pigs receiving antioxidants than in the HC
group (PB/0.05) (Fig. 3C). Median quantitative score
for MMP-1 immunostaining was found to be signifi-
cantly lower (PB/0.05) in the HCV group than in the
HC group (Table 2).
3.4. Effect of native LDL on MMP-1 activity and
expression
Ex vivo experiments performed with supernatants
from cultured porcine coronary rings showed an in-
creased 52 kDa caseinolytic activity in the segments
incubated with LDL obtained from the HC group (Fig.
4A). A weaker ex vivo proteolytic activity could be
observed in the conditioned medium from coronary
rings treated with HCV-LDL than those treated with
HC-LDL; the said activity was later identified as MMP-
1 by Western blot analysis (Fig. 4B).
4. Discussion
Degradation of ECM is a critical event leading to the
weakening of the vessel wall. A mechanistic link between
hypercholesterolemia and collagen loss is still hypothe-
tical, although a critical role of MMPs and other
proteolytic enzymes have also been strongly suggested
[5]. In the present study, we report that a combined
dietary treatment of vitamins C and E restores the
hypercholesterolemia-induced collagen loss and reduces
both vascular and systemic MMP-1 after vascular injury
in pigs. This effect was largely independent of lipid
lowering and occurred despite trivial morphologic
changes in the vessel wall.
We had previously shown that hypercholesterolemia
induces severe structural and morphologic changes in
the vessel wall after angioplasty [11]. This study extends
those findings by showing that Sirius red stained injured
arteries from hypercholesterolemic pigs exhibit extensive
areas devoid of collagen filaments (coinciding with
recent reports [20]) suggesting an increased proteolytic
activity or diminished collagen synthesis. The zymo-
graphic analysis of plasma samples displaying an intense
MMP-1 caseinolytic band as well as an increase in
vascular MMP-1 protein expression would support
those findings. Areas positively stained for MMP-1
were observed mainly in the media and in the intimal
thickening close to internal elastic lamina in the HC
group, thereby confirming previous reports [21/23].
MMP-1 has been shown to be specifically present in
atherosclerotic lesions [6,24], secreted by endothelial
cells, SMC and macrophages and could be involved in
the ECM degradation, which is considered an important
feature for plaque stability [7,25]. Our results show that
areas with the most intense signal were also positive for
SMC and macrophages, confirming that both cellular
types are involved in the MMP-1 vascular expression.
Fig. 2. Caseinolytic activity of plasma samples and quantitative
analysis (top) of proteolytic activity in NC, HC and HCV groups
(A). Quenching experiments performed by simultaneous incubation of
plasma samples with different concentrations (5/50 ng) of a mono-
clonal antibody anti-MMP-1 show the specificity of the caseinolytic
activity (B). Lane 1: molecular weight marker; lane 2: HC plasma
sample; lane 3/5: plasma sample preincubated with 5, 25 and 50 ng of
murine anti-MMP-1 antibody respectively. *PB/0.05 in comparison
with the NC group. $PB/0.05 in comparison with HC group.
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Fig. 3. Immunohistochemical pattern for vascular MMP-1 in the different groups of pigs. Whereas a weak MMP-1 signal (score/1) was present in
NC (panel A) in comparison with the HC (score/3) (B), the vascular immunoreactive MMP-1 expression after angioplasty was significantly reduced
(score/1) in hypercholesterolemic pigs treated with vitamins C and E (panel C), thereby being similar to NC. Areas squared in red correspond to
magnified details. Panel D shows a magnified detail of (B). Panels E and F show the smooth muscle a-actin (E) and macrophages (F) staining of the
same region. Scale bar, 400 mm.
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In a further step, we performed ex vivo experiments in
cultured normal coronary rings to assess the effect of
native LDL, from the three experimental groups, on
MMP-1. The fact that MMP-1 was increased after
stimulation with LDL from hypercholesterolemic pigs
would support the idea that hypercholesterolemia plays
a direct role in the induction of MMP-1 by vascular
cells. According to this data, hypercholesterolemia
would play a significant role in the secretion of MMP-
1 by cells present within the atheroma.
For the first time, we provide evidence that antiox-
idant vitamins C and E, despite a minimum effect on
morphologic changes in the vascular wall, can signifi-
cantly increase the collagen content in hypercholestero-
mic injured arteries, which could be related to a
significant reduction of vascular MMP-1. That effect
was independent of lipid lowering because vitamin
treatment did not alter plasma cholesterol levels. More-
over, the systemic proteolytic activity was also attenu-
ated in the plasma of the pigs receiving antioxidants.
Finally, ex vivo incubation of porcine coronary arteries
with native LDL from hypercholesterolemic pigs treated
with vitamins C and E attenuated the enhancement of
caseinolytic activity induced by hypercholesterolemia.
Based on aforementioned data together, it appears that
the combination of vitamins C and E could reduce the
hypercholesterolemia-induced MMP-1 expression in our
experimental model of vascular injury and, therefore,
prevent ECM degradation by increasing the collagen
content, thus contributing to plaque stabilization. Other
studies have reported a slow progression of athero-
sclerosis in experimental models using antioxidant
vitamins C and E [11,12,26]. In addition, it has been
recently shown that vitamin C deficiency induces a type
of plaque morphology that is potentially vulnerable to
rupture [27].
The mechanism by which antioxidants may partici-
pate in matrix-protective processes remains unclear. We
show herein that the combination of vitamins C/E
reduces plasma lipid peroxidation. Oxidative stress is
increasingly being recognized as a potentially important
contributor to atherogenesis and restenosis after vascu-
lar interventions and injury [28,29]. The generation of
reactive oxygen species and oxidation of lipids have
profound and wide-range effects that can dramatically
increase vascular toxicity and initiate a cascade of
molecular and cellular responses. Increased vascular
expression of MMP-1 in hypercholesterolemia can be a
direct effect of oxidative stress because reactive oxygen
species are known to enhance MMP-1 expression and
activity in vitro [30,31]. Our results, which show that
dietary supplementation with vitamins C/E was able to
significantly reduce plasma lipid peroxidation, support
this hypothesis. In fact, constituents of oxidatively
modified lipoproteins that stimulate protein kinase C
(PKC) might link to the activator protein-1 (AP-1)-
mediated transcriptional regulation that plays a key role
in controlling transcription of MMP-1 [8]. Moreover,
NF-kB, a transcription factor activated by oxidative
stress/free radicals [32], has been shown to be required
for cytokine upregulation of MMP-1 in vascular cells
[33]. a-Tocopherol is a PKC inhibitor capable of
diminishing MMP-1 expression in fibroblast cultures
[34], but it can also inhibit NFkB, resulting in a
significant inhibition of monocyte cell adhesion or
cytokine regulation, which is required for upregulation
of MMP-1 in in vitro studies [33,35].
Our study has some limitations. Other MMPs are also
playing a role in arterial remodeling after injury and
Fig. 4. Effect of purified LDL on MMP-1 induced in coronary artery
rings. Caseinolytic activity of supernatants from LDL-stimulated
porcine rings and quantitative analysis (top) of caseinolytic activity
in NC, HC and HCV groups (A). Western blotting for MMP-1 in
supernatants of cultured aortic rings (B). Lane 1: standard of human
recombinant MMP-1 (52 kDa). Supernatants from cultures incubated
with LDL from HC (lane 2), HCV (lane 3) and NC (lane 4), all three
showing a positive band at 52 kDa size.
Table 2
Semiquantitative score assessment of vascular MMP-1 in the porcine
iliac artery by immunohistochemistry
Group Group size Score Median score
0 1 2 3
NC 6 2 3 1 0 1
HC 6 0 0 3 3 2.5*
HCV 6 0 4 2 0 1
* PB/0.05 in comparison with both NC and HCV.
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ECM degradation. In immunohistochemical staining,
the presence of MMPs assessed by immunohistochem-
istry does not imply increased catalytic capacity [23]. In
addition, matrix catabolism in the cardiovascular system
involves enzymes other than the MMP family, such as
cathepsins and cystatins.
In conclusion, the present study is the first to show an
increase in the neointimal collagen content and a
reduction of vessel-wall MMP-1 in a porcine hyperch-
olesterolemic model of vascular injury in response to
vitamins C and E, thereby suggesting that antioxidant
therapy can contribute to prevent matrix degradation in
atherosclerosis, thus contributing to plaque stabiliza-
tion.
Acknowledgements
This study was supported by grants from the Depar-
tamentos de Salud y Educacio´n (Gobierno de Navarra)
and PIUNA from the University of Navarra and Grant
97/0940 from FIS (Ministerio de Sanidad, Spain).
References
[1] Kakuta T, Usui M, Coats WD, Currier JW, Numano F, Faxon
DP. Arterial remodeling at the reference site after angioplasty in
the atherosclerotic rabbit model. Arterioscler Thromb Vasc Biol
1998;18:47/51.
[2] de Smet BJ, Pasterkamp G, van der Helm YJ, Borst C, Post MJ.
The relation between de novo atherosclerosis remodeling and
angioplasty-induced remodeling in an atherosclerotic Yucatan
micropig model. Arterioscler Thromb Vasc Biol 1998;18:702/7.
[3] Lee RT, Schoen FJ, Loree HM, Lark MW, Libby P. Circumfer-
ential stress and matrix metalloproteinase 1 in human coronary
atherosclerosis. Implications for plaque rupture. Arterioscler
Thromb Vasc Biol 1996;16:1070/3.
[4] Shapiro SD. Matrix metalloproteinase degradation of extracel-
lular matrix: biological consequences. Curr Opin Cell Biol
1998;10:602/8.
[5] Rekhter MD, Hicks GW, Brammer DW, et al. Hypercholester-
olemia causes mechanical weakening of rabbit atheroma: local
collagen loss as a prerequisite of plaque rupture. Circ Res
2000;86:101/8.
[6] Huang Y, Mironova M, Lopes Virella MF. Oxidized LDL
stimulates matrix metalloproteinase-1 expression in human vas-
cular endothelial cells. Arterioscler Thromb Vasc Biol
1999;19:2640/7.
[7] Sukhova GK, Schonbeck U, Rabkin E, Schoen FJ, Poole AR,
Billinghurst RC, Libby P. Evidence for increased collagenolysis
by interstitial collagenases-1 and -3 in vulnerable human ather-
omatous plaques. Circulation 1999;99:2503/9.
[8] Aikawa M, Rabkin E, Okada Y, et al. Lipid lowering by diet
reduces matrix metalloproteinase activity and increases collagen
content of rabbit atheroma: a potential mechanism of lesion
stabilization. Circulation 1998;97:2433/44.
[9] MRC/BHF. Heart protection study of antioxidant vitamin
supplementation in 20,536 high-risk individuals: a randomised
placebo-controlled trial. Lancet 2002;360:23/33.
[10] Fang JC, Kinlay S, Beltrame J, et al. Effect of vitamins C and E
on progression of transplant-associated arteriosclerosis: a rando-
mised trial. Lancet 2002;359:1108/13.
[11] Orbe J, Rodriguez JA, Calvo A, et al. Vitamins C and E attenuate
plasminogen activator inhibitor-1 (PAI-1) expression in a hy-
percholesterolemic porcine model of angioplasty. Cardiovasc Res
2001;49:484/92.
[12] Nunes GL, Sgoutas DS, Redden RA, Sigman SR, Gravanis MB,
King SB, III, Berk BC. Combination of vitamins C and E alters
the response to coronary balloon injury in the pig. Arterioscler
Thromb Vasc Biol 1995;15:156/65.
[13] Rodriguez JA, Grau A, Eguinoa E, et al. Dietary supplementation
with vitamins C and E prevents downregulation of endothelial
NOS expression in hypercholesterolemia in vivo and in vitro.
Atherosclerosis 2002;165:33/40.
[14] de Smet BJ, van der Zande J, van der Helm YJ, Kuntz RE, Borst
C, Post MJ. The atherosclerotic Yucatan animal model to study
the arterial response after balloon angioplasty: the natural history
of remodeling. Cardiovasc Res 1998;39:224/32.
[15] Conti M, Morand PC, Levillain P, Lemonnier A. Improved
fluorometric determination of malonaldehyde. Clin Chem
1991;37:1273/5.
[16] Junqueira LC, Bignolas G, Brentani RR. Picrosirius staining plus
polarization microscopy, a specific method for collagen detection
in tissue sections. Histochem J 1979;11:447/55.
[17] Bullido R, Gomez del Moral M, Alonso F, et al. Monoclonal
antibodies specific for porcine monocytes/macrophages: macro-
phage heterogeneity in the pig evidenced by the expression of
surface antigens. Tissue Antigens 1997;49:403/13.
[18] Chapman MJ, Goldstein S, Lagrange D, Laplaud PM. A density
gradient ultracentrifugal procedure for the isolation of the major
lipoprotein classes from human serum. J Lipid Res 1981;22:339/
58.
[19] Fernandez Resa P, Mira E, Quesada AR. Enhanced detection of
casein zymography of matrix metalloproteinases. Anal Biochem
1995;224:434/5.
[20] Theilmeier G, Quarck R, Verhamme P, et al. Hypercholester-
olemia impairs vascular remodelling after porcine coronary
angioplasty. Cardiovasc Res 2002;55:385/95.
[21] Zempo N, Kenagy RD, Au YP, Bendeck M, Clowes MM, Reidy
MA, Clowes AW. Matrix metalloproteinases of vascular wall cells
are increased in balloon-injured rat carotid artery. J Vasc Surg
1994;20:209/17.
[22] Bendeck MP, Irvin C, Reidy MA. Inhibition of matrix metallo-
proteinase activity inhibits smooth muscle cell migration but not
neointimal thickening after arterial injury. Circ Res 1996;78:38/
43.
[23] Forough R, Koyama N, Hasenstab D, Lea H, Clowes M, Nikkari
ST, Clowes AW. Overexpression of tissue inhibitor of matrix
metalloproteinase-1 inhibits vascular smooth muscle cell functions
in vitro and in vivo. Circ Res 1996;79:812/20.
[24] Hojo Y, Ikeda U, Takahashi M, et al. Matrix metalloproteinase-1
expression by interaction between monocytes and vascular
endothelial cells. J Mol Cell Cardiol 2000;32:1459/68.
[25] Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression
of matrix metalloproteinases and matrix degrading activity in
vulnerable regions of human atherosclerotic plaques. J Clin Invest
1994;94:2493/503.
[26] Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidants and
atherosclerotic heart disease. New Engl J Med 1997;337:408/16.
[27] Nakata Y, Maeda N. Vulnerable atherosclerotic plaque morphol-
ogy in apolipoprotein E-deficient mice unable to make ascorbic
acid. Circulation 2002;105:1485/90.
[28] Huraux C, Makita T, Kurz S, et al. Superoxide production, risk
factors, and endothelium-dependent relaxations in human inter-
nal mammary arteries. Circulation 1999;99:53/9.
J. Orbe et al. / Atherosclerosis 167 (2003) 45/5352
[29] Cai H, Harrison DG. Endothelial dysfunction in cardiovascular
diseases: the role of oxidant stress. Circ Res 2000;87:840/4.
[30] Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS.
Reactive oxygen species produced by macrophage-derived foam
cells regulate the activity of vascular matrix metalloproteinases in
vitro. Implications for atherosclerotic plaque stability. J Clin
Invest 1996;98:2572/9.
[31] Siwik DA, Pagano PJ, Colucci WS. Oxidative stress regulates
collagen synthesis and matrix metalloproteinase activity in cardiac
fibroblasts. Am J Physiol Cell Physiol 2001;280:C53/60.
[32] Li N, Karin M. Is NF-kappaB the sensor of oxidative stress?
FASEB J 1999;13:1137/43.
[33] Bond M, Chase AJ, Baker AH, Newby AC. Inhibition of
transcription factor NF-kappaB reduces matrix metalloprotei-
nase-1, -3 and -9 production by vascular smooth muscle cells.
Cardiovasc Res 2001;50:556/65.
[34] Ricciarelli R, Maroni P, Ozer N, Zingg JM, Azzi A. Age-
dependent increase of collagenase expression can be reduced by
alpha-tocopherol via protein kinase C inhibition. Free Rad Biol
Med 1999;27:729/37.
[35] Chase AJ, Bond M, Crook MF, Newby AC. Role of nuclear
factor-kappa B activation in metalloproteinase-1, -3, and -9
secretion by human macrophages in vitro and rabbit foam cells
produced in vivo. Arterioscler Thromb Vasc Biol 2002;22:765/71.
J. Orbe et al. / Atherosclerosis 167 (2003) 45/53 53
